Skip to content

BriaCell Therapeutics Corp.

BCTX· NasdaqCore metricsCIK 1610820

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -2.52%
Market cap
$30.39M
8.73M shares
Filings
324
—
—
—
-$34.90M
FY 2026N/M FY26 yoy
-$36.05M
FY 2026N/M FY26 yoy
-$28.78M
FY 2026derivedN/M FY26 yoy
-$6.97
FY 2026N/M FY26 yoy
$9.85M
FY 2026−6.1% FY26 yoy
$30.39M
—
—
2.0×
-94.70%
—

FY2026 figures · derived

Price

$3.4864.29%$6.26past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Taxes Other Than Income Taxes

$965.76KFY 2026
$1.04M0FY 2025FY 2026
PeriodEndedValueKindSource trail
FY 20262026-07-31$965,764reported
FY 20252025-07-31$1,039,193reported

Capital returns

Dividends and buybacks · FY2022 to FY2023
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2023—$47.29K$47.29K—15.98M sh+3.0%—
FY2022—$10.17M$10.17M—15.52M sh+1.6%—

Pharmaceutical preparations

BriaCell Therapeutics Corp. is the 363rd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

BriaCell Therapeutics Corp. · CIK 1610820 · Engraved from SEC EDGAR